Twist Bioscience stock drops 4.13% as new Complex Genes launch rolls out, Twist Bioscience

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience drops 4.13% today

Highlights

TWST faces ongoing short-term selling pressure, trading below immediate resistance and near weekly support at $86.54.
Momentum indicators provide conflicting signals, with bullish medium- and long-term trends but near-term indicators reflecting oversold and volatile conditions.
Price is expected to range between $85 and $95 next week, with upside above $95 targeting $98–$100 and strong annual bullish context.

The products are shipped within 15 business days. Twist Bioscience invited customers to explore biology without compromise.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Short-term weakness as resistance holds above bullish trend supports

TWST currently trades at $86.54, below the MA-20 ($93.74) and Ichimoku Kijun ($93.48), with both acting as immediate resistance, while MA-50 at $80.40 offers near-term support and MA-200 at $51.43 serves as key longer-term support. This positioning signals ongoing short-term selling pressure, while the medium- and long-term trend structure remains bullish above the MA-50 and MA-200.

Mixed momentum signals as price slides to weekly range lows

Momentum signals are mixed on D1. MACD shows strong bullish bias and ADX indicates a robust trend, but RSI (46.87) and CCI (-104.47) trend lower and Stoch RSI flags oversold conditions. BBP, however, points to overbought readings, reflecting buying attempts despite intraday selling pressure. Awesome Oscillator is neutral and does not confirm a stronger trend. TWST is trading at $86.54, down from $90.27 a week ago—a decline of 4.13%. The price is now at the very bottom of the weekly range, with volatility at 14.62%. The tone for the week is a steady decline from the highs. In today’s session, the stock has dropped 4.13%, accelerating the move towards weekly support.

High rebound odds as bullish signals outweigh downside risks

For the next week, the adjusted expected price range is $85 to $95, keeping the forecast realistic and within 10% of the current price. This puts the outlook well above the 52-week low ($23.30) and below the 52-week high ($105.41). Based on W1 indicators—RSI, ADX, MACD, and MA-50—all signaling Buy, the probability of an upward move is very high (more than 80%), making a downward scenario less likely. The baseline scenario is for the price to trade sideways between $85 (near MA-50 support) and $95 (immediate resistance at MA-20 and Kijun). A bullish breakout above $95 could prompt a move toward the $98–$100 zone. A bearish break below $85 would risk a further slide toward $80, the next key support. The yearly context remains strongly positive, though the near-term action is corrective.

Previously it was reported that Twist Bioscience was exhibiting a bullish trend with key technical levels in play, highlighting the importance of monitoring support and resistance thresholds. This article adds a new dimension by focusing on emerging market catalysts, suggesting traders keep a close watch on upcoming earnings as a potential driver of the next decisive move.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.